FDA cautions over young donor blood transfusions to treat aging, memory loss
In a warning to consumers on Tuesday, the FDA said consumers should be cautious about establishments offering infusions of plasma obtained from young human donors with the claim that the infused plasma will prevent aging to memory loss.
At a cost of up to thousands of dollars per infusion, the FDA said these establishments, located in several different states, are currently offering infusions of plasma with no proven clinical benefit.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
